[1]贾桂丛 马爱军 沈扬 王凤红 刘建辉 马盼盼 陈文燕.河北省心血管外科围手术期用血现状的多中心回顾性研究[J].中国卫生质量管理,2024,31(06):071-76.[doi:10.13912/j.cnki.chqm.2024.31.6.15]
 JIA Guicong,MA Aijun,SHEN Yang.A Multicenter Retrospective Study of Perioperative Blood Use in Cardiovascular Surgery in Hebei Province[J].Chinese Health Quality Management,2024,31(06):071-76.[doi:10.13912/j.cnki.chqm.2024.31.6.15]
点击复制

河北省心血管外科围手术期用血现状的多中心回顾性研究()
分享到:

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第31卷
期数:
2024年06期
页码:
071-76
栏目:
血液质量
出版日期:
2024-06-15

文章信息/Info

Title:
A Multicenter Retrospective Study of Perioperative Blood Use in Cardiovascular Surgery in Hebei Province
作者:
贾桂丛 马爱军 沈扬 王凤红 刘建辉 马盼盼 陈文燕
河北省血液中心
Author(s):
JIA GuicongMA AijunSHEN Yang
Hebei Blood Center
关键词:
患者血液管理心血管外科围手术期主动脉瓣置换术冠状动脉旁路移植术
Keywords:
Patient Blood ManagementCardiovascular SurgeryPerioperative PeriodAortic Valve Replacement(AVR)Coronary Artery Bypass Graft(CABG)
分类号:
R197.3;R331.1;R654
DOI:
10.13912/j.cnki.chqm.2024.31.6.15
文献标志码:
A
摘要:
目的分析心血管外科围手术期用血现状及异体输血的影响因素,为围手术期血液管理提供参考。方法选取2019年-2020年河北省102家医院共772例主动脉瓣置换术(AVR)和冠状动脉旁路移植术(CABG)患者的临床资料,比较围手术期关键指标、不同血液成分、不同等级医院输血率和输血量的差异,并采用多元线性逐步回归模型分析围手术期异体输血的影响因素。结果2019年-2020年,河北省医院AVR患者异体输血率分别为93.3%和100.0%,CABG患者异体输血率分别为89.4%和90.2%,异体输血率普遍较高。输血概率与医院等级相关,围手术期出血量、手术时长等是影响输血总需求的主要风险因素。结论河北省各医院应建立多学科协同血液管理模式,实施患者血液管理策略,积极推进自体输血技术应用,改良手术方式;相关管理部门应开展临床用血评价与公示,促进各医院严格落实临床用血审核制度,为患者制订合理、科学的输血方案,以降低出血量和异体输血率,进而保障输血安全。
Abstract:
Hebei Blood Center

参考文献/References:

[1]COHN CS,DELANEY M,JOHNSON ST,et al.Technical Manual (AABB).20th Edition[M].Bethesda:American Association of Blood Banks,2020:406-407.[2]MUMTAZ M,WYLER VON BALLMOOS MC,MICHAEL DEEB G,et al.The impact of transfusions on mortality after transcatheter or surgical aortic valve replacement[J].Ann Thorac Surg,2021,112(3):778-785. [3]KOLTE D,BEALE C,ARONOW HD,et al.Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States[J].J Thorac Cardiovasc Surg,2020,159(1):102-111.[4]郑 莹,王泽洲,吴 炅.基于单病种数据库的临床科研平台构建探索[J].中国卫生质量管理,2023,30(7):30-32,47.[5]孙 湛,杨 丽,邵雨婷,等.多学科诊疗模式现状分析与思考[J].中国卫生质量管理,2018,25(6):37-40.[6]张宗久,胡 豫,AXEL HOFMANN,等.促进实施患者血液管理的专家倡议[J].中国卫生质量管理,2022,29(9):81-86.[7]WERNER RS,LIPPS C,WALDHANS S,et al.Blood consumption in total arterial coronary artery bypass grafting[J].J Cardiothorac Surg,2020,15:23.[8]SPADACCIO C,NENNA A,CANDURA D,et al.Total arterial coronary artery bypass grafting in patients with preoperative anemia[J].J Card Surg,2022,37:1528-1536. [9]BJURSTEN H,DARDASHTI A,EDEROTH P,et al.Increased long-term mortality with plasma transfusion after coronary artery bypass surgery[J].Intensive Care Med,2013,39(3):437-444.[10]AYKUT K,ALBAYRAK G,CETIN Y,et al.Coronary artery bypass surgery without blood transfusion:is it possible[J].Niger J Clin Pract,2021,24:59-63. [11]姚京,陈霞,程吉,等.非体外循环冠状动脉旁路移植术大部分患者可不异体输血[J].心脏杂志,2020,32(6):616-619.[12]LU LY,CHE J,CHENG WP,et al.A retrospective study of the relationship between blood transfusion and 30-day postoperative outcomes in patients undergoing isolated off-pump coronary artery bypass grafting[J].Braz J Cardiovasc Surg,2022,37(5):663-673. [13]ZACHAROWSKI K,ZOLLER H,STEINBICKER AU.Patient blood management and patient safety[J].Curr Opin Anesthesiol,2022,35(6):733-737.[14]HARDCASTLE TC.We asked the experts:autotransfusion for the provision of blood in lower-and-middle-income countries[J].World J Surg,2021,45:1979-1981.[15]TIBI P,MCCLURE RS,HUANG JP,et al.STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management[J].Ann Thorac Surg,2021,112(3):981-1004.[16]张巧妮.心血管外科体外循环期综合性患者血液管理措施临床研究[D].北京:北京协和医学院,2023.[17]STANWORTH SJ,DOWLING K,CURRY N,et al.Haematological management of major haemorrhage:a british society for haematology guideline[J].Br J Haematol,2022,198:654-667.[18]中国医师协会心血管外科医师分会,中国医师协会心血管外科分会大血管外科专业委员会.心脏外科手术血液管理专家共识[J].中华胸心血管外科杂志,2015,31(12):715-718. [19]朱 任,黄焕雷.心脏外科手术患者的血液管理[J].中国胸心血管外科临床杂志,2017,24(11):890-895.

相似文献/References:

[1]张宗久胡豫AxelHofmann刘远立纪宏文.促进实施患者血液管理的专家倡议[J].中国卫生质量管理,2022,29(09):081.[doi:10.13912/j.cnki.chqm.2022.29.9.18 ]
 ZHANG Zongjiu,HU Yu,AXEL Hofmann.Expert Initiatives to Promote the Implementation of Patient Blood Management[J].Chinese Health Quality Management,2022,29(06):081.[doi:10.13912/j.cnki.chqm.2022.29.9.18 ]

更新日期/Last Update: 2024-06-15